Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation - Related Studies

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

This study is ongoing, but not recruiting participants.

Study NCT00003883. Last updated on November 16, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer

2	Additional conditions recognized in this trial
		Infection
		Lymphoma, Large-Cell, Immunoblastic
		Lymphoma, Non-Hodgkin

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoma
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		fluconazole
		itraconazole

5	Additional drug interventions recognized in this trial
		Hydroxyitraconazole

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antifungal Agents
		Antiparasitic Agents
		Antiprotozoal Agents
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		Fred Hutchinson Cancer Research Center
		National Cancer Institute (NCI)